These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 34292658)

  • 21. Challenges in assigning endocrine-specific modes of action: Recommendations for researchers and regulators.
    Mihaich EM; Schäfers C; Dreier DA; Hecker M; Ortego L; Kawashima Y; Dang ZC; Solomon K
    Integr Environ Assess Manag; 2017 Mar; 13(2):280-292. PubMed ID: 27976826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Assessment of the Sensitivity of Fish Early-Life Stage, Daphnia, and Algae Tests to the Chronic Ecotoxicity of Xenobiotics: Perspectives for Alternatives to Animal Testing.
    Teixidó E; Leuthold D; de Crozé N; Léonard M; Scholz S
    Environ Toxicol Chem; 2020 Jan; 39(1):30-41. PubMed ID: 31598995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ECETOC Florence workshop on risk assessment of endocrine substances, including the potency concept.
    Fegert I
    Toxicol Lett; 2013 Dec; 223(3):310-4. PubMed ID: 23558296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ecological risk assessment of endocrine disruptors.
    Hutchinson TH; Brown R; Brugger KE; Campbell PM; Holt M; Länge R; McCahon P; Tattersfield LJ; van Egmond R
    Environ Health Perspect; 2000 Nov; 108(11):1007-14. PubMed ID: 11102288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving our understanding of the environmental persistence of chemicals.
    Whale G; Parsons J; van Ginkel K; Davenport R; Vaiopoulou E; Fenner K; Schaeffer A
    Integr Environ Assess Manag; 2021 Nov; 17(6):1123-1135. PubMed ID: 33913596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - Part IV: the ECETOC and CLE Proposal for a Thyroid Function-Related Neurodevelopmental Toxicity Testing and Assessment Scheme (Thyroid-NDT-TAS).
    Melching-Kollmuss S; Bothe K; Charlton A; Gangadharan B; Ghaffari R; Jacobi S; Marty S; Marxfeld HA; McInnes EF; Sauer UG; Sheets LP; Strupp C; Tinwell H; Wiemann C; Botham PA; van Ravenzwaay B
    Crit Rev Toxicol; 2023 Jul; 53(6):339-371. PubMed ID: 37554099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges and Recommendations in Assessing Potential Endocrine-Disrupting Properties of Metals in Aquatic Organisms.
    Brix KV; Baken S; Poland CA; Blust R; Pope LJ; Tyler CR
    Environ Toxicol Chem; 2023 Dec; 42(12):2564-2579. PubMed ID: 37671843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening chemicals for thyroid-disrupting activity: A critical comparison of mammalian and amphibian models.
    Pickford DB
    Crit Rev Toxicol; 2010 Nov; 40(10):845-92. PubMed ID: 20684730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrating emerging science to improve estimates of risk to wildlife from chemical exposure: What are the challenges?
    van den Brink NW; Elliott JE; Power B; Kilgour C; Johnson MS
    Integr Environ Assess Manag; 2024 May; 20(3):645-657. PubMed ID: 38411383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the scientific underpinnings for identifying estrogenic chemicals in nonmammalian taxa using mammalian test systems.
    Ankley GT; LaLone CA; Gray LE; Villeneuve DL; Hornung MW
    Environ Toxicol Chem; 2016 Nov; 35(11):2806-2816. PubMed ID: 27074246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternatives to in vivo tests to detect endocrine disrupting chemicals (EDCs) in fish and amphibians--screening for estrogen, androgen and thyroid hormone disruption.
    Scholz S; Renner P; Belanger SE; Busquet F; Davi R; Demeneix BA; Denny JS; Léonard M; McMaster ME; Villeneuve DL; Embry MR
    Crit Rev Toxicol; 2013 Jan; 43(1):45-72. PubMed ID: 23190036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a Bayesian Network for Strengthening the Weight of Evidence to Predict Acute Fish Toxicity from Fish Embryo Toxicity Data.
    Lillicrap A; Moe SJ; Wolf R; Connors KA; Rawlings JM; Landis WG; Madsen A; Belanger SE
    Integr Environ Assess Manag; 2020 Jun; 16(4):452-460. PubMed ID: 32125082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the relevance of ecotoxicological studies for regulatory decision making.
    Rudén C; Adams J; Ågerstrand M; Brock TC; Poulsen V; Schlekat CE; Wheeler JR; Henry TR
    Integr Environ Assess Manag; 2017 Jul; 13(4):652-663. PubMed ID: 27599457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERGO: Breaking Down the Wall between Human Health and Environmental Testing of Endocrine Disrupters.
    Holbech H; Matthiessen P; Hansen M; Schüürmann G; Knapen D; Reuver M; Flamant F; Sachs L; Kloas W; Hilscherova K; Leonard M; Arning J; Strauss V; Iguchi T; Baumann L
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coral Ecotoxicological Data Evaluation for the Environmental Safety Assessment of Ultraviolet Filters.
    Burns EE; Davies IA
    Environ Toxicol Chem; 2021 Dec; 40(12):3441-3464. PubMed ID: 34758162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toward sustainable environmental quality: Identifying priority research questions for Latin America.
    Furley TH; Brodeur J; Silva de Assis HC; Carriquiriborde P; Chagas KR; Corrales J; Denadai M; Fuchs J; Mascarenhas R; Miglioranza KS; Miguez Caramés DM; Navas JM; Nugegoda D; Planes E; Rodriguez-Jorquera IA; Orozco-Medina M; Boxall AB; Rudd MA; Brooks BW
    Integr Environ Assess Manag; 2018 May; 14(3):344-357. PubMed ID: 29469193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
    Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk assessment of 'endocrine substances': guidance on identifying endocrine disruptors.
    Lewis RW
    Toxicol Lett; 2013 Dec; 223(3):287-90. PubMed ID: 24036001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A European perspective on alternatives to animal testing for environmental hazard identification and risk assessment.
    Scholz S; Sela E; Blaha L; Braunbeck T; Galay-Burgos M; García-Franco M; Guinea J; Klüver N; Schirmer K; Tanneberger K; Tobor-Kapłon M; Witters H; Belanger S; Benfenati E; Creton S; Cronin MT; Eggen RI; Embry M; Ekman D; Gourmelon A; Halder M; Hardy B; Hartung T; Hubesch B; Jungmann D; Lampi MA; Lee L; Léonard M; Küster E; Lillicrap A; Luckenbach T; Murk AJ; Navas JM; Peijnenburg W; Repetto G; Salinas E; Schüürmann G; Spielmann H; Tollefsen KE; Walter-Rohde S; Whale G; Wheeler JR; Winter MJ
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):506-30. PubMed ID: 24161465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When Are Adverse Outcome Pathways and Associated Assays "Fit for Purpose" for Regulatory Decision-Making and Management of Chemicals?
    Coady K; Browne P; Embry M; Hill T; Leinala E; Steeger T; Maślankiewicz L; Hutchinson T
    Integr Environ Assess Manag; 2019 Jul; 15(4):633-647. PubMed ID: 30908812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.